Healthcare provider profile · identity verified

John Mark Stauffer, MD

Family Practice · ROCKINGHAM, VA · NPI 1538190434

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Furosemide	Furosemide	705	116
Levothyroxine Sodium	Levothyroxine Sodium	597	94
Eliquis	Apixaban	564	77
Atorvastatin Calcium	Atorvastatin Calcium	424	88
Amlodipine Besylate	Amlodipine Besylate	315	57
Metoprolol Succinate	Metoprolol Succinate	293	60
Potassium Chloride	Potassium Chloride	282	55
Metoprolol Tartrate	Metoprolol Tartrate	275	48
Sertraline Hcl	Sertraline Hcl	266	44
Quetiapine Fumarate	Quetiapine Fumarate	256	33
Trazodone Hcl	Trazodone Hcl	249	56
Tamsulosin Hcl	Tamsulosin Hcl	241	43
Losartan Potassium	Losartan Potassium	220	38
Lisinopril	Lisinopril	191	30
Omeprazole	Omeprazole	185	43
Memantine Hcl	Memantine Hcl	172	27
Donepezil Hcl	Donepezil Hcl	161	28
Gabapentin	Gabapentin	159	44
Levetiracetam	Levetiracetam	149	22
Buspirone Hcl	Buspirone Hcl	148	27
Diclofenac Sodium	Diclofenac Sodium	148	27
Famotidine	Famotidine	146	29
Xarelto	Rivaroxaban	144	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	139	36
Spironolactone	Spironolactone	132	34
Rosuvastatin Calcium	Rosuvastatin Calcium	128	25
Clopidogrel	Clopidogrel Bisulfate	125	25
Duloxetine Hcl	Duloxetine Hcl	115	21
Warfarin Sodium	Warfarin Sodium	106	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	102	28
Latanoprost	Latanoprost	100	18
Carvedilol	Carvedilol	97	26
Carbidopa-Levodopa	Carbidopa/Levodopa	91	16
Methenamine Hippurate	Methenamine Hippurate	91	suppressed
Prednisone	Prednisone	89	25
Finasteride	Finasteride	82	15
Hydrochlorothiazide	Hydrochlorothiazide	77	13
Oxycodone Hcl	Oxycodone Hcl	77	38
Triamcinolone Acetonide	Triamcinolone Acetonide	75	29
Simvastatin	Simvastatin	74	15
Cephalexin	Cephalexin	66	32
Fluticasone Propionate	Fluticasone Propionate	66	19
Metformin Hcl	Metformin Hcl	66	18
Nystatin	Nystatin	63	28
Allopurinol	Allopurinol	60	12
Mirtazapine	Mirtazapine	60	14
Baclofen	Baclofen	56	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	56	14
Ropinirole Hcl	Ropinirole Hcl	55	13
Trulicity	Dulaglutide	54	16
Carbidopa-Levodopa Er	Carbidopa/Levodopa	53	suppressed
Divalproex Sodium	Divalproex Sodium	53	suppressed
Citalopram Hbr	Citalopram Hydrobromide	52	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	51	suppressed
Pravastatin Sodium	Pravastatin Sodium	50	11
Bumetanide	Bumetanide	49	17
Amiodarone Hcl	Amiodarone Hcl	47	20
Montelukast Sodium	Montelukast Sodium	47	suppressed
Ezetimibe	Ezetimibe	46	suppressed
Lorazepam	Lorazepam	46	16
Bupropion Xl	Bupropion Hcl	45	suppressed
Terazosin Hcl	Terazosin Hcl	45	suppressed
Tramadol Hcl	Tramadol Hcl	44	18
Timolol Maleate	Timolol Maleate	43	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	42	12
Oxybutynin Chloride	Oxybutynin Chloride	42	suppressed
Entresto	Sacubitril/Valsartan	41	suppressed
Hydralazine Hcl	Hydralazine Hcl	41	11
Ipratropium Bromide	Ipratropium Bromide	41	11
Lamotrigine	Lamotrigine	41	suppressed
Permethrin	Permethrin	39	34
Ondansetron Hcl	Ondansetron Hcl	37	21
Esomeprazole Magnesium	Esomeprazole Magnesium	36	suppressed
Midodrine Hcl	Midodrine Hcl	35	17
Dicyclomine Hcl	Dicyclomine Hcl	34	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Amantadine	Amantadine Hcl	33	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	33	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	33	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Albuterol Sulfate	Albuterol Sulfate	31	17
Januvia	Sitagliptin Phosphate	31	suppressed
Farxiga	Dapagliflozin Propanediol	29	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	29	suppressed
Ondansetron Odt	Ondansetron	29	11
Creon	Lipase/Protease/Amylase	28	suppressed
Alprazolam	Alprazolam	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	12
Nifedipine Er	Nifedipine	27	13
Nuedexta	Dextromethorphan Hbr/Quinidine	27	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	26	17
Clonazepam	Clonazepam	26	suppressed
Lactulose	Lactulose	26	suppressed
Rytary	Carbidopa/Levodopa	26	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Atropine Sulfate	Atropine Sulfate	25	suppressed
Atenolol	Atenolol	24	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	24	suppressed
Celecoxib	Celecoxib	24	suppressed
Olanzapine	Olanzapine	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Alendronate Sodium	Alendronate Sodium	23	suppressed
Azithromycin	Azithromycin	23	14
Dapagliflozin	Dapagliflozin Propanediol	23	suppressed
Fluconazole	Fluconazole	23	14
Cefuroxime	Cefuroxime Axetil	22	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	13
Clonidine	Clonidine	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Sodium Chloride	0.9 % Sodium Chloride	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Digoxin	Digoxin	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Ketoconazole	Ketoconazole	19	12
Methotrexate	Methotrexate Sodium	19	suppressed
Piperacillin-Tazobactam	Piperacillin Sodium/Tazobactam	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Loperamide	Loperamide Hcl	17	14
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Lithium Carbonate	Lithium Carbonate	16	suppressed
Metolazone	Metolazone	16	suppressed
Primidone	Primidone	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	suppressed
Valsartan	Valsartan	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Budesonide Ec	Budesonide	15	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	15	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Restasis Multidose	Cyclosporine	15	suppressed
Torsemide	Torsemide	15	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	14	14
Haloperidol Lactate	Haloperidol Lactate	14	suppressed
Risperidone	Risperidone	14	suppressed
Topiramate	Topiramate	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Ceftriaxone	Ceftriaxone Sodium	13	suppressed
Levalbuterol Hcl	Levalbuterol Hcl	13	suppressed
Trintellix	Vortioxetine Hydrobromide	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	12	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	12	suppressed
Glycopyrrolate	Glycopyrrolate	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error